Starlight Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Starlight Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression (NCT07431216) | Starlight Therapeutics Inc. | 2026-05-01 |
Track Starlight Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.